Imipramine stimulates phospholipase C activity in rat brain

Area of Science:

• Neuropharmacology
• Cellular Neuroscience
• Biochemistry

Background:

• Antidepressant drugs (ADs) are known to influence intracellular calcium (Ca2+) signaling pathways.
• Previous research indicated ADs induce Ca2+ release from inositol 1,4,5-trisphosphate-sensitive stores in neuronal cultures.

Purpose of the Study:

• To elucidate the mechanism by which tricyclic ADs activate phospholipase C (PLC) in the rat frontal cortex.
• To investigate the specific PLC isoform involved in the imipramine-mediated activation.

Main Methods:

• Measurement of PLC activity in rat frontal cortex membranes and cytosol using an exogenous substrate.
• Concentration-dependent assay of imipramine's effect on PLC activity.
• Testing the effects of other tricyclic ADs, Li+, and pargyline on PLC activity.
• Investigating the role of Ca2+ in imipramine-induced PLC activation.
• Utilizing isoform-specific antibodies (anti-PLC-beta 1, anti-PLC-gamma 1, anti-PLC-delta 1) to identify the activated PLC isoform.

Main Results:

• Imipramine, desipramine, and amitriptyline significantly stimulated PLC activity in a concentration-dependent manner.
• Imipramine showed synergistic activation of PLC in the presence of Ca2+, indicating a distinct mechanism from Ca2+-dependent activation.
• Imipramine activated PLC in both membrane and cytosol fractions.
• Preincubation with anti-PLC-beta 1 antibody blocked imipramine-mediated PLC activation, while anti-PLC-gamma 1 and anti-PLC-delta 1 had no effect.

Conclusions:

• Tricyclic ADs, specifically imipramine, directly activate PLC-beta 1 in the rat frontal cortex.
• This activation occurs independently of traditional receptor or guanine nucleotide-binding protein (G protein) signaling pathways.
• The findings provide a novel mechanistic insight into how certain antidepressants modulate neuronal signaling.